Mr. Speaker, my question is for the Minister of Health. The minister knows that Health Canada officials have now confirmed that it is okay for a private company to charge $2,500 for PET scans for heart patients, but not for cancer. This means that the rich can buy access to clinical trials and it is an assault on the foundations of medicare.
Instead of denying access to this important diagnostic test, will the minister ban companies from charging for clinical trials? Will she clearly include these medically necessary diagnostic services under the Canada Health Act, as Roy Romanow has recommended?